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Review
In the Netherlands (16.9 million inhabitants), blood units 
are nationally provided by Sanquin Blood Supply, which 
includes a nationally organized rare donor program. Since 
the 1970s, donated red blood cell (RBC) units with rare blood 
types have been frozen and stored. This began as part of the 
European Bank of Frozen Blood of the Council of Europe, with 
contributions from several European countries. In 2006, this 
became the Sanquin Bank of Frozen Blood (SBFB). In early 
2015, 1294 units of frozen blood with rare phenotypes were 
stored at the SBFB.
Sanquin Blood Bank uses a cohort of 380,000 regular, 
repeat blood donors and approximately 900 active rare donors, 
who are negative for a high-prevalence antigen. All donors 
donate on a voluntary basis and no incentives are given to rare 
donors.
We have different methods to enlarge the rare donor 
cohort. First, patients who have been identified with RBC 
alloantibodies and found to be negative for a high-prevalence 
antigen are asked to become rare donors. Second, family 
members of these patients are tested and asked to become 
donors if they are also negative for the antigen. Third, Sanquin 
Blood Bank types donors for different RBC antigens such 
as k, Lub, and Kpb on a regular basis.  In general, we add 
approximately 15 new rare donors to our database each year. 
When rare blood is needed, we prefer the use of a fresh unit 
from one of the rare donors rather than a deglycerolized unit.
Although the rare donor cohort consists of several rare 
blood types, and requests in general can be filled, there is a 
shortage of rare donors with non-Caucasian phenotypes 
such as U– or Js(b–). Currently, we are evaluating whether 
we should make more effort to find non-Caucasian donors to 
extend the rare donor population. Furthermore, extremely rare 
donors such as Rhnull or K0 donors are lacking in our cohort.
Issued Units
Rare RBC units, either deglycerolized or fresh, issued 
between January 2008 and December 2014 for patients in 
the Netherlands are shown in Figure 1. All requests during 
this period were filled. The only incompatible units transfused 
during this time period were for a few patients with weakly 
reactive (<2+) anti-Yta because Rh-matched, Yt(a–) units were 
not available and no transfusion reactions were expected. In 
these cases, no additional measures were taken. 
From 2008 to 2014, a total of 434 units of fresh RBCs were 
issued. Of these units, 429 (99%) originated from Dutch donors. 
In the same period, 98 units of RBCs with rare phenotypes 
were thawed and deglycerolized through the SBFB. Of these 
deglycerolized units, 63 (64%) originated from Dutch donors, 























Fig. 1. Overview of the phenotypes of issued units of rare red blood 
cells (RBCs) in the Netherlands, both fresh and deglycerolized, 
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and the other 35 units (36%) were received from blood banks 
outside the Netherlands. The 434 units of fresh RBCs were 
issued for 137 patients and the 98 units of deglycerolized 
RBCs were issued for 40 patients. Of the patients who received 
fresh RBCs, 118 (86%) patients were female, of whom 57 
were pregnant. A total of 100 (23%) units were issued during 
delivery. For the units of deglycerolized RBCs, 26 (70%) were 
for female patients of whom 10 were pregnant; 16 units (16%) 
were deglycerolized for use during delivery.
In the group of patients who received fresh RBCs, 28 
patients (20%) received autologous units, as compared with 16 
(40%) patients who received deglycerolized RBCs.
Conclusions
Thanks to the national rare donor program, a steep 
increase in the issue of fresh RBC units and a decrease in the 
issue of deglycerolized RBC units have been observed in the 
last 7 years (Fig. 2). Of the fresh units of RBCs issued, 100 were 
ordered for female patients during delivery as compared with 
10 units of deglycerolized RBCs. The relatively high proportion 
of units of fresh RBCs ordered for pregnant patients during 
delivery can be explained by the fact that it is easier and less 
costly to order units of fresh RBCs as a preventive measure 
than units of deglycerolized RBCs, ensuring a substantial 
contribution to optimize a patient’s safety.
The overall contribution of autologous units is low, 
especially for fresh RBCs.
Because of the national rare donor program, almost 
all donors of fresh RBCs and a majority of the donors of the 
deglycerolized RBCs are of Dutch origin, thereby providing 
a self-sufficient blood supply. International collaboration, 
however, remains very important, especially when there is a 
need to find compatible blood for patients with non-Caucasian 
phenotypes.
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Fig. 2. Overview of the total amount of fresh and deglycerolized red 
blood cell (RBC) units issued in the Netherlands between 2008 
and 2014.
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